Investigating how Tau protein affects RNA processing in Alzheimer's disease
Tau-RNA crosstalk: Alternative Poly-Adenylation (APA) Regulation in Alzheimer's Disease
This study is looking at how a protein called Tau, which is linked to Alzheimer's disease, affects the way our brain cells process important messages needed for their health, with the hope of finding new ways to treat or diagnose the disease.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Med Br Galveston NIH-funded |
| Lab location | 1 site (Galveston, United States) |
| Project ID | NIH-10952630 on NIH RePORTER |
What this research studies
This research explores the role of Tau protein in Alzheimer's disease, particularly how its misfolding impacts RNA processing and gene expression. By examining the mechanisms of Alternative Poly-Adenylation (APA), the study aims to understand how changes in Tau affect the stability and function of mRNAs in neurons. The researchers will use an inducible Tau cell model to analyze the expression of mRNAs that encode RNA-Binding Proteins (RBPs), which are crucial for neuronal health. The goal is to uncover potential pathways that could lead to new treatments or diagnostic methods for Alzheimer's disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or related dementias.
Not a fit: Patients with other forms of dementia not related to Alzheimer's may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing or treating Alzheimer's disease by targeting RNA processing mechanisms.
How similar studies have performed: While the specific approach of examining Tau-RNA interactions in the context of Alzheimer's is relatively novel, related research has shown promise in understanding the role of Tau in neurodegenerative diseases.
Where this research is happening
Galveston, United States
- University of Texas Med Br Galveston — Galveston, United States (Active)
Researchers
- Principal investigator: Montalbano, Mauro — University of Texas Med Br Galveston
- Study coordinator: Montalbano, Mauro
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.